CREBBP and acute myeloid leukemia: We then analyzed the selective dependency on EP300 and CREBBP of a series of leukemia compared to other tumor cells in DepMap database, highlighting EP300/CREBBP potential targeting in AML cells (Additional file 1: Figure S1A).